» Articles » PMID: 28487332

Neurocognitive Performance After Cerebral Revascularization in Adult Moyamoya Disease

Overview
Journal Stroke
Date 2017 May 11
PMID 28487332
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Cerebral revascularization using EC-IC bypass is widely used to treat moyamoya disease, but the effects of surgery on cognition are unknown. We compared performance on formal neurocognitive testing in adults with moyamoya disease before and after undergoing direct EC-IC bypass.

Methods: We performed a structured battery of 13 neurocognitive tests on 84 adults with moyamoya disease before and 6 months after EC-IC bypass. The results were analyzed using reliable change indices for each test, to minimize test-retest variability and practice effects.

Results: Twelve patients (14%) showed significant decline postoperatively, 9 patients (11%) improved, and 63 patients (75%) were unchanged. Similar results were obtained when the analysis was confined to those who underwent unilateral (33) or bilateral (51) revascularization.

Conclusions: The majority of patients showed neither significant decline nor improvement in neurocognitive performance after EC-IC bypass surgery. Uncomplicated EC-IC bypass seems not to be a risk factor for cognitive decline in this patient population.

Citing Articles

Cognitive dysfunction in Moyamoya disease: latest developments and future directions.

Wang X, Liu Z, Zhou Z, Zhang J, Wang Y, He S Front Hum Neurosci. 2024; 18:1502318.

PMID: 39713171 PMC: 11659249. DOI: 10.3389/fnhum.2024.1502318.


Influence of an improvement in frontal lobe hemodynamics on neurocognitive function in adult patients with moyamoya disease.

Tsunoda S, Inoue T, Ohwaki K, Takeuchi N, Shinkai T, Fukuda A Neurosurg Rev. 2024; 47(1):395.

PMID: 39093494 DOI: 10.1007/s10143-024-02639-y.


Neuropsychiatric Symptoms of Moyamoya Disease: Considerations for the Clinician.

Oakley C, Lanzino G, Klaas J Neuropsychiatr Dis Treat. 2024; 20:663-669.

PMID: 38532905 PMC: 10964779. DOI: 10.2147/NDT.S440975.


MRI hypoperfusion as a determinant of cognitive impairment in adults with Moyamoya angiopathy.

Giroud M, Planton M, Darcourt J, Raposo N, Brandicourt P, Mirabel H Eur Stroke J. 2024; 9(3):732-742.

PMID: 38501882 PMC: 11418512. DOI: 10.1177/23969873241240829.


Moyamoya Disease Causing Stroke in the Setting of Cocaine Use and Uncontrolled Hypertension Due to Primary Hyperaldosteronism.

DeRon Jr N, Fischer F, Norris T Cureus. 2024; 16(1):e51578.

PMID: 38313982 PMC: 10835197. DOI: 10.7759/cureus.51578.